DOW Quote, Financials, Valuation and Earnings

Corteva has a net margin of -0.51% compared to Dow's net margin of -1.03%. Dow's return on equity of 5.97% beat Corteva's return on equity of 3.64%.

Dow has a consensus price target of $41.45, signalling upside risk potential of 45.8%. On the other hand Corteva has an analysts' consensus of $69.30 which suggests that it could grow by 16.9%. Given that Dow has higher upside potential than Corteva, analysts believe Dow is more attractive than Corteva.

Dow has a beta of 1.064, which suggesting that the stock is 6.393% more volatile than S&P 500. In comparison Corteva has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.2%.

Dow has a quarterly dividend of $0.70 per share corresponding to a yield of 9.85%. Corteva offers a yield of 1.13% to investors and pays a quarterly dividend of $0.17 per share. Dow pays 176.17% of its earnings as a dividend. Corteva pays out 50.5% of its earnings as a dividend. Corteva's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Dow's is not.

Dow quarterly revenues are $10.4B, which are larger than Corteva quarterly revenues of $4B. Dow's net income of -$53M is lower than Corteva's net income of -$41M. Notably, Dow's price-to-earnings ratio is 18.11x while Corteva's PE ratio is 45.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dow is 0.47x versus 2.44x for Corteva. Usually stocks with elevated PS ratios are considered overvalued.

Eastman Chemical has a net margin of -0.51% compared to Dow's net margin of 14.7%. Dow's return on equity of 5.97% beat Eastman Chemical's return on equity of 15.92%.

Dow has a consensus price target of $41.45, signalling upside risk potential of 45.8%. On the other hand Eastman Chemical has an analysts' consensus of $110.91 which suggests that it could grow by 41.56%. Given that Dow has higher upside potential than Eastman Chemical, analysts believe Dow is more attractive than Eastman Chemical.

Dow has a beta of 1.064, which suggesting that the stock is 6.393% more volatile than S&P 500. In comparison Eastman Chemical has a beta of 1.384, suggesting its more volatile than the S&P 500 by 38.405%.

Dow has a quarterly dividend of $0.70 per share corresponding to a yield of 9.85%. Eastman Chemical offers a yield of 4.19% to investors and pays a quarterly dividend of $0.83 per share. Dow pays 176.17% of its earnings as a dividend. Eastman Chemical pays out 41.88% of its earnings as a dividend. Eastman Chemical's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Dow's is not.

Dow quarterly revenues are $10.4B, which are larger than Eastman Chemical quarterly revenues of $2.2B. Dow's net income of -$53M is lower than Eastman Chemical's net income of $330M. Notably, Dow's price-to-earnings ratio is 18.11x while Eastman Chemical's PE ratio is 10.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dow is 0.47x versus 0.98x for Eastman Chemical. Usually stocks with elevated PS ratios are considered overvalued.

Green Plains has a net margin of -0.51% compared to Dow's net margin of -9.41%. Dow's return on equity of 5.97% beat Green Plains's return on equity of -9%.

Dow has a consensus price target of $41.45, signalling upside risk potential of 45.8%. On the other hand Green Plains has an analysts' consensus of $11.11 which suggests that it could grow by 193.95%. Given that Green Plains has higher upside potential than Dow, analysts believe Green Plains is more attractive than Dow.

Dow has a beta of 1.064, which suggesting that the stock is 6.393% more volatile than S&P 500. In comparison Green Plains has a beta of 1.205, suggesting its more volatile than the S&P 500 by 20.453%.

Dow has a quarterly dividend of $0.70 per share corresponding to a yield of 9.85%. Green Plains offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dow pays 176.17% of its earnings as a dividend. Green Plains pays out -6.26% of its earnings as a dividend.

Dow quarterly revenues are $10.4B, which are larger than Green Plains quarterly revenues of $584M. Dow's net income of -$53M is higher than Green Plains's net income of -$54.9M. Notably, Dow's price-to-earnings ratio is 18.11x while Green Plains's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dow is 0.47x versus 0.10x for Green Plains. Usually stocks with elevated PS ratios are considered overvalued.

Nucor has a net margin of -0.51% compared to Dow's net margin of 4.06%. Dow's return on equity of 5.97% beat Nucor's return on equity of 9.33%.

Dow has a consensus price target of $41.45, signalling upside risk potential of 45.8%. On the other hand Nucor has an analysts' consensus of $150.82 which suggests that it could grow by 35.58%. Given that Dow has higher upside potential than Nucor, analysts believe Dow is more attractive than Nucor.

Dow has a beta of 1.064, which suggesting that the stock is 6.393% more volatile than S&P 500. In comparison Nucor has a beta of 1.666, suggesting its more volatile than the S&P 500 by 66.625%.

Dow has a quarterly dividend of $0.70 per share corresponding to a yield of 9.85%. Nucor offers a yield of 1.96% to investors and pays a quarterly dividend of $0.55 per share. Dow pays 176.17% of its earnings as a dividend. Nucor pays out 25.75% of its earnings as a dividend. Nucor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Dow's is not.

Dow quarterly revenues are $10.4B, which are larger than Nucor quarterly revenues of $7.1B. Dow's net income of -$53M is lower than Nucor's net income of $287M. Notably, Dow's price-to-earnings ratio is 18.11x while Nucor's PE ratio is 13.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dow is 0.47x versus 0.86x for Nucor. Usually stocks with elevated PS ratios are considered overvalued.